Ovalum Vascular, Ltd. (Ovalum) developed a vascular interventional guidewire for use in crossing difficult and chronic total occlusions in peripheral and coronary arteries. Ovalum’s principal product, the Voletek GuidewireTM, has been approved for use in peripheral arteries in both the U.S. and Europe. The Fund exited its investment in Ovalum in 2014.